Everforth Inc annual report, Q4 FY1999

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Reporting Period: Fiscal year ended December 31, 1999.
Business Overview: A nationwide provider of temporary scientific, clinical, environmental, and healthcare financial professionals. The company operates through two primary segments: Lab Support (combining Lab Support, Clinical Lab Staff, and EnviroStaff divisions) and Healthcare Financial Staffing. As of year-end 1999, the company operated 144 branch offices across 68 markets in the U.S., Canada, and the U.K.

Key Financial Metrics (Year Ended Dec 31, 1999)

Metric 1999 Value 1998 Value
Revenues $159,473,000 $132,741,000
Cost of Services $107,652,000 $90,705,000
Gross Profit $51,821,000 $42,036,000
Gross Margin 32.5% 31.7%
Operating Income $21,393,000 $16,728,000
Net Income $14,462,000 $11,316,000
Diluted EPS $1.29 $1.00
Cash & Equivalents $24,120,000 $27,706,000
Working Capital $54,769,000 $43,987,000
Long-Term Debt $0 $0

Cash Flow: Net cash provided by operating activities was $10,110,000 in 1999, a decrease from $11,622,000 in 1998, primarily due to increased accounts receivable and deferred income taxes. Net cash used for investing activities was $7,934,000, driven by purchases of marketable securities and equipment. Net cash used for financing activities was $5,770,000, largely due to $7,812,000 in common stock repurchases.

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 20.1% year-over-year, driven by growth in both the Lab Support and Healthcare Financial Staffing segments. This was primarily due to an increased number of temporary employees on assignment and, to a lesser extent, higher average hourly billing rates.
  • Segment Performance: The Lab Support segment saw revenue growth offset slightly by a decline in the EnviroStaff division as it transitioned away from remediation business. Healthcare Financial Staffing revenues grew significantly due to increased assignments in established markets.
  • Profitability: Gross margin improved from 31.7% to 32.5% due to decreased workers' compensation and unemployment insurance expenses. Operating expenses as a percentage of revenue remained stable at 19.1%.
  • International Expansion: The company commenced operations in the United Kingdom (Lab Support UK) in the first quarter of 1999 and expanded its Canadian operations.
  • Stock Repurchases: The company repurchased 330,000 shares of common stock for $7,812,000 during 1999 under a $15 million authorization.

Guidance, Outlook, and Risks

Outlook: Management intends to expand services domestically and internationally in existing fields (laboratory, clinical, environmental, medical billing) and potentially enter new professional fields. The company plans to leverage its "Account Manager System" for expansion.

Risks and Contingencies:

  • Seasonality: The business experiences seasonal declines in demand during the year-end holiday season through February and during summer months (June-August).
  • Competition: The industry is highly competitive with low barriers to entry. Major competitors include Manpower, Kelly Services, and Adecco, which have greater financial resources.
  • Key Personnel: Success relies heavily on the ability to recruit, train, and retain qualified Account Managers and temporary professionals.
  • International Risks: Expansion into the U.K. and Europe introduces risks related to currency fluctuations, regulatory differences, and limited experience in non-North American markets.
  • Workers' Compensation: The company is partially self-insured for workers' compensation. While reserves are deemed reasonable, there is no assurance they will be adequate to cover all claims.
  • Year 2000: The company reported no significant Year 2000 issues affecting operations post-1999.

Investor Verification Checklist

  • Stock Split Impact: Verify the impact of the 2-for-1 stock split authorized on March 7, 2000 (effective April 3, 2000), which is not retroactively reflected in the 1999 financial statements.
  • Contingent Acquisition Consideration: Confirm the status of the potential additional $480,000 payment related to the 1998 LabStaffers acquisition, contingent on revenue targets.
  • Workers' Compensation Reserves: Review the adequacy of the $1,447,000 accrued liability for workers' compensation claims given the partially self-insured nature of the program.
  • International Performance: Monitor the financial contribution and integration challenges of the new U.K. and Canadian operations in upcoming quarters.
  • Accounts Receivable: Assess the $22,780,000 accounts receivable balance and the $1,216,000 allowance for doubtful accounts, noting the increase in receivables contributed to lower operating cash flow in 1999.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.